Baraldo M - Search Results

1

Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures.

Benetello P, Furlanut M, Baraldo M, Tonon A, Furlanut M. Benetello P, et al. Among authors: baraldo m. Eur Neurol. 2002;48(4):200-3. doi: 10.1159/000066165. Eur Neurol. 2002. PMID: 12422067

2

Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations.

Benetello P, Furlanut M, Zara G, Baraldo M, Hassan E. Benetello P, et al. Among authors: baraldo m. Eur Neurol. 1993;33(1):69-73. doi: 10.1159/000116905. Eur Neurol. 1993. PMID: 8440292

3

Oral gabapentin disposition in patients with epilepsy after a high-protein meal.

Benetello P, Furlanut M, Fortunato M, Baraldo M, Pea F, Tognon A, Testa G. Benetello P, et al. Among authors: baraldo m. Epilepsia. 1997 Oct;38(10):1140-2. doi: 10.1111/j.1528-1157.1997.tb01204.x. Epilepsia. 1997. PMID: 9579961 Free article. Clinical Trial.

4

Imipramine pharmacokinetics in depressed geriatric patients.

Benetello P, Furlanut M, Zara G, Baraldo M. Benetello P, et al. Among authors: baraldo m. Int J Clin Pharmacol Res. 1990;10(3):191-5. Int J Clin Pharmacol Res. 1990. PMID: 2228344

5

Chronopharmacokinetics of ciclosporin and tacrolimus.

Baraldo M, Furlanut M. Baraldo M, et al. Clin Pharmacokinet. 2006;45(8):775-88. doi: 10.2165/00003088-200645080-00002. Clin Pharmacokinet. 2006. PMID: 16884317 Review.

6

Educational and organizational interventions to improve the usefulness of clinical pharmacological advice for personalized drug dosing based on therapeutic drug monitoring.

Pea F, Dose L, Cojutti P, Baraldo M, Fontana F, Favaretti C, Furlanut M. Pea F, et al. Among authors: baraldo m. Basic Clin Pharmacol Toxicol. 2014 Nov;115(5):432-7. doi: 10.1111/bcpt.12249. Epub 2014 May 3. Basic Clin Pharmacol Toxicol. 2014. PMID: 24703163 Free article.

7

Side effects of imipramine therapy in enuretic children.

Montanari G, Baraldo M, Zara G, Benetello P, Secchieri S, Furlanut M. Montanari G, et al. Among authors: baraldo m. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:103-4. doi: 10.1016/s1043-6618(09)80051-0. Pharmacol Res. 1990. PMID: 2097617 No abstract available.

8

Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients.

Baraldo M, Zara G, Benetello P, Furlanut M. Baraldo M, et al. Pharmacol Res. 1990 Sep-Oct;22 Suppl 1:119-20. doi: 10.1016/1043-6618(90)90837-4. Pharmacol Res. 1990. PMID: 2284227 No abstract available.

9

Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association.

Benetello P, Furlanut M, Fortunato M, Pea F, Baraldo M. Benetello P, et al. Among authors: baraldo m. Pharmacol Res. 1997 Apr;35(4):313-5. doi: 10.1006/phrs.1997.0145. Pharmacol Res. 1997. PMID: 9264047 Clinical Trial.

10

Chlorpromazine disposition in relation to age in children.

Furlanut M, Benetello P, Baraldo M, Zara G, Montanari G, Donzelli F. Furlanut M, et al. Among authors: baraldo m. Clin Pharmacokinet. 1990 Apr;18(4):329-31. doi: 10.2165/00003088-199018040-00005. Clin Pharmacokinet. 1990. PMID: 2323156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters